abstract |
Disclosed are novel inorganic acid salts of sibutramine, which have good physicochemical properties, and crystalline forms thereof . Also disclosed are pharmaceutical compositions comprising the compounds as effective ingredients, methods of preparing the compounds, and the use of the compounds. |